Abstract While there has been increasing interest in the use of preoperative breast magnetic resonance imaging (MRI) for women with breast cancer, little is known about trends in MRI use, or the association of MRI with surgical approach among older women. Using the Surveillance, Epidemiology and End Results-Medicare database, we identified a cohort of women diagnosed with breast cancer from 2000 to 2009 who underwent surgery. We used Medicare claims to identify preoperative breast MRI and surgical approach. We evaluated temporal trends in MRI use according to age and type of surgery, and identified factors associated with MRI. We assessed the association between MRI and surgical approach: breast-conserving surgery (BCS) versus mastectomy, bilateral versus unilateral mastectomy, and use of contralateral prophylactic mastectomy. Among the 72,461 women in our cohort, 10.1 % underwent breast MRI. Preoperative MRI use increased from 0.8 % in 2000-2001 to 25.2 % in 2008-2009 (p \ 0.001). Overall, 43.3 % received mastectomy and 56.7 % received BCS. After adjustment for clinical and demographic factors, MRI was associated with an increased likelihood of having a mastectomy compared to BCS (adjusted odds ratio = 1.21, 95 % CI 1.14-1.28). Among women who underwent mastectomy, MRI was significantly associated with an increased likelihood of having bilateral cancer diagnosed (9.7 %) and undergoing bilateral mastectomy (12.5 %) compared to women without MRI (3.7 and 4.1 %, respectively, p \ 0.001 for both).
Introduction
The use of preoperative breast magnetic resonance imaging (MRI) for newly diagnosed breast cancer patients is controversial. Advocates for incorporating this imaging modality into the surgical management of women with newly diagnosed breast cancer suggest that the extent of disease can be more accurately assessed and additional mammographically and/or sonographically occult lesions can be detected with MRI [1] [2] [3] . Yet there is increasing evidence that the use of breast MRI in newly diagnosed patients confers no advantage with respect to attainment of negative margins, or lower rates of reoperation [4, 5] .
Despite the paucity of evidence and the high cost of the test, the number of women who undergo MRI prior to surgical resection is increasing [6] [7] [8] [9] . Between 2005 and 2008, preoperative MRI use among women younger than 64 years of age, who were undergoing breast cancer surgery, increased from 22.8 to 52.9 % [9] . As increasing age is inversely related to time at risk for disease progression and recurrence, cancer management strategies must be carefully scrutinized across all age strata [10, 11] . That is, with increasing age and shorter life expectancy, the clinical benefit of detecting occult lesions on MRI is likely to diminish. Hence, while the benefits of preoperative MRI are still being determined, it is particularly important to understand MRI use among older women with breast cancer. Earlier studies have found that the use of preoperative MRI among Medicare beneficiaries increased from 3.9 % in 2003 to 10.1 % in 2005 [8] . In addition to assessing MRI use in the Medicare program using more recent data, several knowledge gaps regarding the clinical impact of MRI use remain.
Breast MRI has high sensitivity for detecting breast abnormalities, including additional loci of invasive disease. In prior studies, largely including younger patients, preoperative MRI detected additional foci of mammographically occult disease in the ipsilateral breast in 11-31 % of newly diagnosed breast cancer patients [12] with approximately 3 % diagnosed with additional breast cancer in the contralateral breast [13] . However, the impact of MRI on contralateral disease detection at the population level remains to be assessed. Preoperative MRI might alter surgical management strategies in part through detecting additional invasive lesions on the contralateral breast. As a result, concern has been expressed that the use of breast MRI is contributing to rising mastectomy rates [14] . Mastectomy is not without potential complications, especially when immediate reconstruction is performed [15] . A national UK audit of over 3,000 women found a 16 % readmission rate for complications and a 10 % implant loss rate [16] . Yet little is known about how the diffusion of MRI is affecting mastectomy use among Medicare beneficiaries with breast cancer. Further, given that MRI can increase detection of lesions in the contralateral breast, it is important to determine the relation between MRI use and receipt of bilateral mastectomy.
Amidst uncertainty about how new technologies are affecting patient outcomes, and concerns about rising cancer care costs, understanding the clinical implications of new imaging strategies is crucial. We therefore assessed the use of breast MRI among female Medicare beneficiaries who were diagnosed with breast cancer in 2000-2009 to describe imaging and surgical trends for the treatment of unilateral and bilateral breast cancer over the same time period, and to assess the association between receipt of preoperative MRI and the extent of surgical treatment.
Methods

Overview
Among older women who underwent surgery for breast cancer, we used Medicare claims to identify the use of preoperative breast MRI within 6 months prior to surgery. We observed temporal trends and factors associated with the use of MRI and assessed the relation between preoperative MRI and surgery type.
Data source
The Surveillance, Epidemiology and End Results (SEER)-Medicare database provides sociodemographic and cancer characteristics for patients residing in SEER regions linked with Medicare claims. The registry covers approximately 28 % of the US population. The Yale Human Investigation Committee determined that this study did not constitute human subjects research.
Study sample
We identified all women diagnosed with stages I-III invasive breast cancer during 2000-2009 who underwent surgery and were at least 67-year-old at the time of breast cancer diagnosis. We excluded patients if: (1) breast cancer was not the first tumor diagnosis reported to SEER, or Medicare claims indicated a history of cancer in the 2 years before diagnosis; (2) the tumor was reported by autopsy or death certificate only; (3) tumor histology was not of epithelial origin; (4) month or stage of diagnosis was missing; or (5) patients did not have continuous fee-for-service Medicare Part A and Part B coverage from 2 years before diagnosis through death or December 31, 2011, whichever occurred first. We also excluded women with breast cancer diagnosed in the Greater Georgia registry before 2004, as we did not have complete claims to assess their MRI use and comorbidity, and women with no Medicare claims in the 24 months before through 12 months after cancer diagnosis, as these women were likely receiving cancer treatment outside the Medicare system.
Exposure and outcome ascertainment
We identified preoperative breast MRI according to Healthcare Common Procedure Coding System (HCPCS) codes (Appendix). Type of surgery was identified using HCPCS codes and their modifiers, as well as International Classification for Diseases, Ninth Revision (ICD-9) procedure codes. Breast surgery was classified into breastconserving surgery (BCS) or mastectomy, with further subdivision of mastectomy according to unilateral or bilateral mastectomy [17] . We defined bilateral breast cancer as a SEER report where laterality indicated bilateral involvement or a diagnosis of breast cancer in the contralateral breast between the month of diagnosis and breast cancer surgery. Women who received bilateral mastectomy, but were not identified as having bilateral breast cancer, were classified as receiving contralateral prophylactic mastectomy.
Covariate creation and selection
Covariates included age, race, marital status, year of diagnosis, median household income at the zip code level, and SEER region. We used Elixhauser comorbid conditions, adapting an approach which requires the diagnosis code to appear on an inpatient claim or two or more physician or outpatient claims greater than 30 days apart for the condition to be considered present (Appendix) [18] . We also assessed stage, grade, tumor size, hormone receptor status, and number of positive lymph nodes as reported by SEER.
Statistical analysis
We used Chi squared tests to evaluate the association between demographic and clinical characteristics and MRI. We evaluated the trends in MRI use over time by age group and in combination with the type of mastectomy (bilateral vs. unilateral) using Cochran-Armitage and Jonckheere-Terpstra tests of trend. We identified factors associated with undergoing preoperative MRI using multivariable logistic regression.
We used multivariable logistic regression to assess the association between preoperative MRI and the extent of the surgery (BCS vs. mastectomy). Among women who underwent mastectomy, we then evaluated the association between MRI and type of mastectomy (unilateral or bilateral). Finally, we used multinomial logistic regression to assess the association between preoperative MRI and the following surgery types: (1) bilateral mastectomy for the treatment of unilateral breast cancer (i.e., contralateral prophylactic mastectomy), (2) unilateral mastectomy for the treatment of bilateral breast cancer, (3) bilateral mastectomy for the treatment of bilateral breast cancer, and (4) unilateral mastectomy for the treatment of unilateral breast cancer (reference). All analyses were conducted using SAS (version 9.2, SAS Institute, Inc., Cary, NC).Tests were twosided with an alpha value of 0.05.
Results
There were a total of 72,461 women in the analysis. The majority was white, had early stage disease, and had estrogen receptor (ER) positive tumors (Table 1) . Overall, 10.1 % (n = 7,333) underwent preoperative breast MRI (Table 2) . Women who underwent MRI were more likely to be younger, white, of higher median income, and have less comorbidity compared to those who did not (p B 0.001 for all).
The use of breast MRI increased steadily over the study period, from 0. Of the 31,373 women who underwent mastectomy, 4.8 % had a bilateral mastectomy (Table 3 ). The use of bilateral mastectomy almost doubled over the study period, Fig. 2 ). While there was a significant increase in bilateral mastectomy among both women who did and did not receive preoperative breast MRI over time (p for trend both \0.001), women who had an MRI were more likely to have a bilateral procedure than those who did not (12.5 vs. 4.1 %, p \ 0.001, Table 3 ). After adjusting for patient and clinical factors, preoperative MRI was associated with a significantly increased likelihood of having bilateral versus unilateral mastectomy (AOR = 1.98, 95 % CI 1.72-2.29).
Receipt of MRI was also associated with diagnosis of bilateral disease among women who underwent a mastectomy. While 3.7 % of women who did not receive MRI were diagnosed with bilateral breast cancer, 9.7 % of women who received an MRI were diagnosed with bilateral breast cancer (p \ 0.001). Accordingly, as MRI use increased over time, the percentage of mastectomy patients diagnosed with bilateral breast cancer increased from 3.6 % in 2000 to 5.2 % in 2009 (p for trend \0.001).
We then distinguished bilateral mastectomy performed in the setting of bilateral breast cancer, from bilateral mastectomy performed in the setting of unilateral breast cancer (contralateral prophylactic mastectomy). Preoperative breast MRI use was significantly associated with the 
Discussion
We observed a significant increase in the use of preoperative breast MRI among Medicare beneficiaries with early stage breast cancer from 2000 to 2009. The use of preoperative MRI was more prevalent across the study period among women in younger age groups, with one in three women age 75 and under receiving an MRI by the end of the study period, despite the lack of evidence linking MRI use to superior outcomes. By 2009, 10 % of women in the oldest age category (85-94-years-old) were receiving preoperative MRI. This study builds upon prior work in several ways. We not only demonstrated that preoperative MRI has diffused rapidly into the care of older women with breast cancer, but have also found that this imaging strategy is associated with important changes in management. Women who received an MRI were more likely to subsequently undergo more aggressive surgical treatment, such as mastectomy (compared to BCS), or bilateral (compared to unilateral) mastectomy. Notably, the majority of the increase in use of bilateral mastectomy during the study period was in women who had undergone preoperative MRI.
The association between MRI use and mastectomy is concerning for several reasons. First, evidence does not support mastectomy as a superior strategy. Six prospective randomized trials have proven BCS to be no less effective than mastectomy for breast cancer treatment [19] [20] [21] [22] [23] [24] . Tenyear local recurrence rates after BCS in trials conducted in the 1970s ranged from 3.5 to 6.5 % and are considerably less than 5 % when adjuvant hormone and radiotherapy are given. This is particularly true for the well differentiated, hormone receptor positive cancers commonly seen among elderly women. Second, research has shown improved body image and lower rates of depression among women of all ages with BCS compared to mastectomy [25] . Third, potential complications and length of hospital stay associated with mastectomy are more numerous than for BCS, especially among older women with multiple comorbidities, and especially when reconstruction is performed [16] . BCS and sentinel lymph node biopsy with or without axillary dissection can usually be performed as outpatient surgery and are associated with less time under anesthesia and fewer complications than mastectomy. Lastly, BCS is less costly to the healthcare system than mastectomy at 5 years [26] . In light of these compelling reasons to pursue BCS when feasible, it is difficult to appreciate an added value of more extensive surgery brought about by the use of preoperative MRI. While there are cases where mastectomy is necessary for early stage disease, it is likely that many of the women in this study would have been well served with BCS and appropriate adjuvant treatment. Fear of recurrence and poorer survival may in part be driving this trend toward MRI use and more extensive surgery, but this is difficult to measure. A recent study by Fisher et al. [27] reported that approximately 40 % of women elected mastectomy when BCS was an option, with fear of recurrence and perceived improvement in survival cited as the most common reasons. It is also possible that some women elected to undergo a mastectomy to avoid radiotherapy. However, assuming that a similar percentage would have needed radiotherapy at the beginning of the study, this trend toward more aggressive surgery is likely related to preoperative MRI, rather than the avoidance of radiation.
Among those undergoing mastectomy, we also observed an increased rate of bilateral mastectomy, regardless of whether bilateral cancer was present. The increased use of contralateral prophylactic mastectomy is provocative, as the risk of developing a contralateral breast cancer is only 0.5-1.0 % per year among women treated for a unilateral cancer [28] . It is possible that additional suspicious areas seen on MRI, which were not biopsied prior to surgery, contributed to increased patient anxiety and the desire for contralateral prophylactic mastectomy. A recent analysis concluded that contralateral prophylactic mastectomy was not cost effective for women over the age of 70; this group represented about 80 % of our sample [29] [30] [31] .
While we have demonstrated that MRI is associated with higher rates of detection of contralateral cancers, the impact that these contralateral foci of disease have on survival is unknown at the population level [32] . It is possible that hormone therapy, which is very effective against the ER positive tumors that older women are likely to present with, may be an effective treatment. Clearly, further research is needed to evaluate the long-term outcomes and the survival benefit, if any, with regard to small contralateral cancer detection. This is particularly important, as bilateral mastectomy does confer an even greater risk of adverse events than unilateral mastectomy [33] [34] [35] [36] . The use of a large, population-based database allows us to report on national trends in the use of MRI and breast cancer surgery; however, we are limited by a lack of clinical variables that will be important to include in future analyses. We were not able to link pathologic information to suspicious MRI findings, cannot identify multicentric disease, assess family history of breast cancer or presence BRCA mutations, or evaluate breast density (a factor which renders mammography less sensitive) [37, 38] . In addition, we were unable to measure the effect that patient anxiety associated with MRI had on the decision to undergo mastectomy.
It is unclear why the use of MRI has increased so rapidly. Clinicians are not responding to a new groundswell of medical evidence; neither of the two large, prospective randomized trials to evaluate preoperative breast MRI use demonstrated a clinical benefit [39, 40] . We can only speculate that patient preference to have an MRI, providers' concerns about performing surgery without a ''complete'' evaluation, and reimbursement incentives may have played a role in the rapid dissemination of breast MRI. Provider practice style is likely a driving factor: a recent survey of practicing surgeons reveals wide variation in breast MRI recommendation for recently diagnosed patients-with about one in five recommending it to \10 % of their patients, and about one in ten surgeons recommending it to[95 % of their patients [41] . Forty-one percent of surgeons routinely (C75 % of the time) recommended the test, with these proportions varying by practice volume, specialization, and practice type. With ''personal experience'' being the leading influence on its utilization, the trend is likely to increase [41] .
In summary, the use of preoperative breast MRI has increased dramatically among older women and is associated with an increased rate of mastectomy among those undergoing surgery. In order to inform decision making, the benefits and harms of MRI-and the accompanying change in surgical approach-need to be established. Recent studies have also demonstrated the adoption of newer and more expensive breast cancer screening and treatment approaches in the Medicare population, with scant evidence to support them [42] [43] [44] . Our study suggests that breast imaging may be considered in a similar category: it is expensive, affects clinical care, yet has little evidence to supports its use. It is time for policy makers to invest in a comprehensive approach to study breast cancer management among older women with breast cancer. : 19110, 19120, 19125, 19126, 19160, 19162, 19301, 19302 ICD-9 Procedure: 85.20-85. 23, 85.25 Mastectomy HCPCS: 19180, 19182, 19200, 19220, 19240, 19303, 19304, 19305, 19306, 19307 ICD-9 Procedure: 85.41-85.48
Elixhauser comorbidity conditions assessed
Congestive heart failure, cardiac arrhythmia, valvular disease, pulmonary circulation disorders, peripheral vascular disorders, paralysis, other neurological disorders, chronic pulmonary disease, diabetes, renal failure, liver disease, AIDS/HIV, rheumatoid arthritis, coagulopathy, weight loss, fluid and electrolyte disorders, blood loss anemia, deficiency anemia, alcohol abuse, drug abuse, psychoses, depression
